About Bilayer Therapeutics
Bilayer Therapeutics is a private company based in Cambridge, Massachusetts, incorporated in 2020 in Delaware. It has reported $2,300,000 raised in two offerings on Form D since April 2021.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Aug 3, 2023 | Aug 4, 2023 | $300,000of $1.0M target | 1 | $300K | Debt, OptionsRule 506(b) | Form D ↗ |
| Apr 19, 2021 | Apr 29, 2021 | $2,000,000of $3.6M target | 2 | $1.0M | EquityRule 506(b) | Form D ↗ |
| Total, two offerings | $2,300,000 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Bilayer Therapeutics's Form D filed Aug 4, 2023.
JK
Joshua Korzenik
Director
TC
Thomas Collet
President and director
RL
Robert Langer
Director
HC
Huang Yen-Chen
Director
DZ
David Zhu
Director
CT
Carlo Traverso
Director
Earlier filings also listed Carlo Giovanni (director, last listed Apr 2021).